PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Univ. Lille, INSERM, Institut Pasteur de Lille, U1177, F-59000 Lille, France.\', \'Aix Marseille Univ. CNRS, AFMB UMR 7257, Marseille, France.\', \'Univ. Bordeaux, Allée Geoffroy St Hilaire, 33615 Pessac, France; INSERM, LAMC, UMR 1029, Allée Geoffroy St Hilaire, 33615 Pessac, France.\', \'Univ. Lille, INSERM, Institut Pasteur de Lille, U1177, F-59000 Lille, France. Electronic address: bruno.villoutreix@inserm.fr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0928-0987(20)30284-010.1016/j.ejps.2020.105495
?:hasPublicationType
?:journal
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
is ?:pmid of
?:pmid
?:pmid
  • 32730844
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all